CYP2D6 and brain neoplasm: Patients with stroke showed differences as compared to patients with brain tumors (P < 0.05), and both patients with brain tumors or with cranial nerve neuropathies differed in their CYP2D6 phenotype with regard to controls (P < 0.05).